Using the SCIEX QTRAP 4500 system
S.Uhlen1, C. Marzullo1, A. Morla2
1Hospital of Mulhouse, Mulhouse, France; 2SCIEX, France
β-Lactam antibiotics are the most widely used class of drugs for the treatment of bacterial infections in human for many years. As antibiotic resistance can be an issue, rapid methods of analysis are needed. Here, a method for rapid LC-MS/MS quantification of 9 B-lactam antibiotics in human samples on the SCIEX QTRAP 4500 System was developed. The method uses a simple protein precipitation and fast chromatography and provides sensitivity, linearity, and robustness for such analysis in plasma samples.
β-Lactam are among the most widely used class of drugs for the treatment of bacterial infections in humans. Most β-lactam antibiotics work by inhibiting cell wall biosynthesis in the bacterial organism. Bacteria often develop resistance to these antibiotics by synthesizing a β-lactamase, an enzyme that attacks the β-lactam ring common to this class of antibiotic. To overcome this resistance, β-lactam antibiotics can be given with β-lactamase inhibitors such as clavulanic acid. The antibacterial characteristics the drugs display are dependent on both the concentration of drug in relation to the minimum inhibitory concentration (MIC) and the time that this exposure is maintained. Therefore, monitoring their concentrations in plasma is of high importance.1
The commonality of the structures of the β-lactam class of antibiotics can be seen in Figure 1. This class includes among others, penicillin derivatives (penams), cephalosporins (cephems) and penems.
In this technical note, a fast LC-MS/MS method with a simple sample preparation on the QTRAP 4500 system is described for the quantitative analysis of nine β-lactams antibiotics, amoxicillin (AMO), cloxacillin (CLO), piperacillin (PIP), cephazolin (CEP), cefotaxime (CEFO), ceftazidime (CEFT) and cefepime (CEFE), imipenem (IMI) and meropenem (MER).
Sample preparation: 100 μL of each sample, calibrator or QC was spiked with 10 μL of internal standard mix at 100 μg/mL. Protein precipitation was carried out by the addition of 200 μL of methanol containing 0.1% formic acid. Following vortex mixing, the samples were centrifuged for 10 minutes before the supernatant was transferred to autosampler vials for injection.
Liquid chromatography: Chromatographic separation was accomplished using a Phenomenex Kinetex Biphenyl column (100 x 2.1 mm, 2.6 μm). Water with 0.1% formic acid (A) and methanol with 0.1% formic acid (B) were used as mobile phase solvents. 1 μL of prepared samples was injected into the UHPLC system. A fast gradient elution method was employed with a total run time of 8 minutes. An example chromatogram is shown in Figure 2.
Mass spectrometry: MS/MS detection was performed using the SCIEX QTRAP 4500 system equipped with Turbo V ion source using electrospray ionization, operating in positive mode. Multiple reaction monitoring (MRM) mode was employed, using two specific transitions of each analyte. The primary transition was used for quantification while the secondary transition was used for confirmation through the generation of ion ratios. Dwell and cycle times were optimized using the Scheduled MRM algorithm. Table 1 shows the summarized results of optimized MRM transitions and parameters of the nine β-Lactam antibiotics and their respective isotope-labeled internal standards. For imipenem, meropenem-d6 was used as the internal standard.
Data processing: Data were acquired using Analyst software and processed using SCIEX OS software.
Figure 3 shows examples of chromatograms obtained from the lowest calibrator sample. As can be seen, the polar compound imipenem eluted early on the chromatography used, and the resolved split peak is due to a mixture of two rotational Z and E formamidinium isomers in equilibrium2.
Calibration curves over the concentration ranges between 1 and 150 μg/mL for all analytes except imipenem (0.05 to 7.5 μg/mL) and meropenem (0.1 to 15 μg/mL) are reported in Figure 4. Curves were generated using a 1/x weighted linear regression of the peak-area ratios of the antibiotic to corresponding internal standard. Regression coefficients (r2) of all calibration curves were greater than 0.99 with back-calculated concentrations of the calibration samples within ±15% (±20% at LLOQ) of the nominal concentrations. The recorded accuracy and precision were within EMA guidelines (European Medicines Agency, Science Medicines Health, 2011).
The application of this multiplexed targeted assay for nine β-lactams antibiotics has been demonstrated using plasma samples from the Hospital of Mulhouse Antibiotic Therapeutic Drug Monitoring (TDM) program previously analyzed for these antibiotics by alternative methods.1 Examples of chromatograms at concentrations recorded are shown in Figure 5.
Presented here are the results from the development of a simple, sensitive and robust assay utilizing the SCIEX QTRAP 4500 system coupled with fast UHPLC chromatography for the analysis of nine β-lactam antibiotics in human plasma. The method demonstrated the following advantages: